Coronavirus Live Count Map India
remove_red_eye 706 Views
COVID-19 Vaccine Updates
#Infectious Diseases #Public Health #Pulmonary Medicine
The Centers for Disease Control and Prevention (CDC) has issued new recommendations for tuberculosis (TB) skin testing in response to the anticipated 3- to 10-month nationwide shortage of Aplisol (Par Pharmaceuticals), a purified-protein derivative (PPD) tuberculin antigen approved by the US Food and Drug Administration (FDA) for tuberculin skin tests (TSTs).
The report was published this week in MMWR. The CDCs recommendations are intended to address the potential decrease in TB testing because of the shortage.